CVS
CVS Health Corp
CVS Health Corp historical holders
total: 20
Clipper Fund CVS Health Corp transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2024 Q4
- Held for:
- 6 quarters
- Latest activity:
- 2024 Q4
Christopher Davis has been an institutional investor in CVS Health Corp (CVS) since 2024 Q4. According to 2026 Q1 report, Christopher Davis holds 781,360 shares with a market value of roughly $56.12M representing 4.20% of their equity portfolio. The fund/company first acquired CVS in 2024 Q4, initially purchasing 781,360 shares.
Does Christopher Davis still hold CVS?
Yes, Christopher Davis continues to hold CVS Health Corp (CVS). According to their 2026 Q1 report, they maintain a position of 781,360 shares valued at approximately $56.12M, representing 4.20% of their equity portfolio.
When did Christopher Davis first invest in CVS?
Christopher Davis first invested in CVS Health Corp (CVS) in 2024 Q4 at the reported quarter-end price of $44.89 per share, acquiring 781,360 shares in their initial purchase.
What is Christopher Davis's average cost basis for CVS?
Based on historical transaction data, Christopher Davis's estimated cost basis for CVS Health Corp (CVS) is approximately $44.89 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $44.89
CVS transactions history by Clipper Fund
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
3.05%
|
781,360
|
$44.89
|
$35,075,250
|
new
|
+3.05%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.